All In MedTech

Device Trial Radar · NCT04712526

Endostapler Gastric Bypass Study

Safety and Efficacy of the AEON™ Endostapler in Laparoscopic Roux-en-Y Gastric Bypass Surgery

Last checked: Nov 20, 2026Latest source record: Oct 4, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Withdrawn

Status

Withdrawn

Enrollment

0

Actual

Start

Jan 18, 2021

Primary completion

Nov 2023

Study completion Dec 2023

Sponsor

Lead sponsor
Lexington Medical Inc.Not on our public-company list
Sponsor type
Industry
First posted
Jan 15, 2021

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The goal of this prospective, post-market study is to evaluate safety and efficacy of the AEON™ Endostapler when used in laparoscopic Roux-en-Y gastric bypass surgery.

Conditions

  • Obesity

Interventions

  • AEON EndostaplerDevice

    Surgery with AEON Endostapler

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of reported device-related adverse eventsTime frame: Within 30-day post-operative period

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Holyoke Medical Center

    Holyoke, Massachusetts

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.